226 related articles for article (PubMed ID: 9118350)
1. Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: implications for the treatment of CNS disorders.
Behan DP; Grigoriadis DE; Lovenberg T; Chalmers D; Heinrichs S; Liaw C; De Souza EB
Mol Psychiatry; 1996 Sep; 1(4):265-77. PubMed ID: 9118350
[TBL] [Abstract][Full Text] [Related]
2. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
[TBL] [Abstract][Full Text] [Related]
3. Physiological roles of urocortins, human homologues of fish urotensin I, and their receptors.
Suda T; Kageyama K; Sakihara S; Nigawara T
Peptides; 2004 Oct; 25(10):1689-701. PubMed ID: 15476936
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides.
Behan DP; De Souza EB; Lowry PJ; Potter E; Sawchenko P; Vale WW
Front Neuroendocrinol; 1995 Oct; 16(4):362-82. PubMed ID: 8557170
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
[TBL] [Abstract][Full Text] [Related]
6. Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides.
Boorse GC; Denver RJ
Gen Comp Endocrinol; 2006 Mar; 146(1):9-18. PubMed ID: 16413023
[TBL] [Abstract][Full Text] [Related]
7. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
Hoare SR; Sullivan SK; Fan J; Khongsaly K; Grigoriadis DE
Peptides; 2005 Mar; 26(3):457-70. PubMed ID: 15652653
[TBL] [Abstract][Full Text] [Related]
8. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.
Vaughan J; Donaldson C; Bittencourt J; Perrin MH; Lewis K; Sutton S; Chan R; Turnbull AV; Lovejoy D; Rivier C
Nature; 1995 Nov; 378(6554):287-92. PubMed ID: 7477349
[TBL] [Abstract][Full Text] [Related]
9. Three-amino acid motifs of urocortin II and III determine their CRF receptor subtype selectivity.
Jahn O; Tezval H; van Werven L; Eckart K; Spiess J
Neuropharmacology; 2004 Aug; 47(2):233-42. PubMed ID: 15223302
[TBL] [Abstract][Full Text] [Related]
10. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2.
Tsatsanis C; Androulidaki A; Dermitzaki E; Gravanis A; Margioris AN
J Cell Physiol; 2007 Mar; 210(3):774-83. PubMed ID: 17117478
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
[TBL] [Abstract][Full Text] [Related]
12. Role of corticotropin releasing factor receptor subtype 1 in stress-related functional colonic alterations: implications in irritable bowel syndrome.
Taché Y; Martinez V; Million M; Maillot C
Eur J Surg Suppl; 2002; (587):16-22. PubMed ID: 16144197
[TBL] [Abstract][Full Text] [Related]
13. Monkey corticotropin-releasing factor1 receptor: Complementary DNA cloning and pharmacological characterization.
Oshida Y; Ikeda Y; Chaki S; Okuyama S
Life Sci; 2004 Feb; 74(15):1911-24. PubMed ID: 14761672
[TBL] [Abstract][Full Text] [Related]
14. Ancient evolution of stress-regulating peptides in vertebrates.
Chang CL; Hsu SY
Peptides; 2004 Oct; 25(10):1681-8. PubMed ID: 15476935
[TBL] [Abstract][Full Text] [Related]
15. Expression and effects of metabotropic CRF1 and CRF2 receptors in rat small intestine.
Porcher C; Juhem A; Peinnequin A; Sinniger V; Bonaz B
Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1091-103. PubMed ID: 15637181
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord.
Korosi A; Kozicz T; Richter J; Veening JG; Olivier B; Roubos EW
J Comp Neurol; 2007 Jun; 502(6):973-89. PubMed ID: 17444496
[TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing factor receptors and urocortins, links between the brain and the heart.
Yang LZ; Tovote P; Rayner M; Kockskämper J; Pieske B; Spiess J
Eur J Pharmacol; 2010 Apr; 632(1-3):1-6. PubMed ID: 20132811
[TBL] [Abstract][Full Text] [Related]
18. Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease.
Behan DP; Heinrichs SC; Troncoso JC; Liu XJ; Kawas CH; Ling N; De Souza EB
Nature; 1995 Nov; 378(6554):284-7. PubMed ID: 7477348
[TBL] [Abstract][Full Text] [Related]
19. Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA.
Pollandt S; Liu J; Orozco-Cabal L; Grigoriadis DE; Vale WW; Gallagher JP; Shinnick-Gallagher P
Eur J Neurosci; 2006 Sep; 24(6):1733-43. PubMed ID: 17004937
[TBL] [Abstract][Full Text] [Related]
20. Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brain.
Korosi A; Veening JG; Kozicz T; Henckens M; Dederen J; Groenink L; van der Gugten J; Olivier B; Roubos EW
Brain Res; 2006 Feb; 1072(1):46-54. PubMed ID: 16423327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
